Citations 346
DDIS-01. THE ANTIBODY-DRUG CONJUGATE ABT-414 DEMONSTRATES SINGLE-AGENT ANTI-CANCER ACTIVITY ACROSS A PANEL OF GBM PATIENT-DERIVED XENOGRAFTS
Marin, Bianca M. , Hu, Zeng, Carlson, Brett L. , Marin, Bianca M , Mladek, Ann C. , Burgenske, Danielle M. , He, Lihong , Bakken, Katrina K. , Schroeder, Mark A. , Sarkaria, Jann N.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi69-vi69
CADD-57. THE EFFICACY OF THERAPY WITH ABT-414, AN EGFR-TARGETING ADC, IS POTENTIALLY ALTERED BY HETEROZYGOUS DELETION OF THE ENDOCYTIC TRAFFICKING REGULATOR RBSN
Muller-Greven, Gaëlle, Marin, Bianca M. , Carlin, Cathleen R. , Reilly, Edward B. , Bredel, M., Gladson, Candece L. , Marin, Bianca M , Müller-Greven, Gaëlle, Lee, Jeongwu , Sarkaria, Jann N.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi283-vi284
RDNA-04. POTENTIAL MECHANISM OF TEMOZOLOMIDE-MEDIATED RADIO-SENSITIZATION IN MGMT HYPERMETHYLATED GLIOBLASTOMA CELLS
Kitange, Gaspar J. , Smith, Emily, Gupta, Shiv K. , Sarkaria, Jann N.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi222-vi222
DRES-17. ACTIVATION OF FGF SIGNALING PATHWAY CONFERS RESISTANCE TO EGFR INHIBITION IN GBM
Gong, Ke , Habib, Amyn A. , Guo, Gao , Sarkaria, Jann N.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi79-vi79
TMOD-11. IMAGING BASED INVASION METRIC PREDICTIVE OF RESPONSE TO ABT414 IN ORTHOTOPIC EGFRviii AMPLIFIED PATIENT DERIVED XENOGRAFTS
Marin, Bianca M. , Paulson, Lisa, Kasle, Lauren, Jackson, Pamela , Marin, Bianca M , Massey, Susan Christine , Hawkins‐Daarud, Andrea , Mladek, Ann C. , Sarkaria, Jann N. , Swanson, Kristin R
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi270-vi271
TMIC-36. LOCAL TISSUE BIOMARKERS OF RESPONSE TO THERAPY FOR GLIOBLASTOMA
Olson, Ian , Jacobs, Joshua , Rajani, Karishma , Macura, Slobodan , Sarkaria, Jann N. , Burns, Terry C.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi264-vi264
DDIS-25. TARGETING GLIOBLASTOMA HETEROGENEITY WITH miR-34a
Khan, Muhammad Babar , Ruggieri, Rosamaria, MacDiarmid, Jennifer A. , Brahmbhatt, Himanshu , Boockvar, John A. , Symons, Marc , Tran, Nhan L. , Sarkaria, Jann N.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi74-vi74
ACTR-12. PRELIMINARY SAFETY AND EFFICACY OF A PHASE II TRIAL OF 18F-DOPA PET-GUIDED, DOSE-ESCALATED RADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA
Pafundi, Deanna, Anderson, S. Keith , Zakhary, Mark J. , Tseung, Hok Seum Wan Chan, Lowe, Val J. , Yan, Elizabeth , Kizilbash, Sani H. , Uhm, Joon H. , Hu, Leland , Brown, Paul D. , Buckner, Jan C. , Brinkmann, Debra H. , Kizilbash, Sani H , Laack, Nadia N. , Hunt, Christopher H. , Kaufmann, Timothy J. , Sarkaria, Jann N.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi13-vi13
TMOD-07. LOCALIZATION OF ERLOTONIB RELATIVE TO MRI-BASED TUMOR EXTENT IN PDX GLIOBLASTOMA MODEL: TOWARDS A MATHEMATICAL MODEL FOR THE INTERFACE BETWEEN MRI AND DRUG DISTRIBUTION
Jackson, Pamela , Ranjbar, Sara , Randall, Elizabeth C., Lopez, Begona, Hu, Leland , Regan, Michael S. , Abdelmoula, Walid M. , Lopez, Begona, Massey, Susan Christine , He, Lihong , Macura, Slobodan , Agar, Jeffrey N. , Sarkaria, Jann N. , Agar, Nathalie Y.R. , Swanson, Kristin R
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi269-vi270
GENE-20. A NOVEL K-M ENHANCER REGULATES TEMOZOLOMIDE RESISTANCE AND TUMOR GROWTH IN GLIOBLASTOMA
Chen, Xiaoyue , Gan, Haiyun , Fang, Dong, Kitange, Gaspar J. , Hu, Zeng, Chen, Xiaoyue, Zhang, Minjie , Lee, Jeong‐Heon , Fang, Dong, He, Lihong , Zhang, Zhiguo , Sarkaria, Jann N.
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi107-vi107